Tag: Lola Eniola-Adefeso
-
U-M spinout Asalyxa Bio developing inflammatory treatment platform, aiding COVID-19 patients
The company’s technology delivers an anti-inflammatory agent directly to overreactive neutrophils, minimizing harm from “cytokine storms.”
-
How rod-shaped particles might distract an out-of-control immune response
When white blood cells don’t know when to stop, an injection of rod-shaped particles may draw them away from a site of excessive inflammation.
-
Nanoparticles can limit inflammation by distracting the immune system
White blood cells get busy taking out the trash – it could be a lifesaver when the immune system goes haywire.